Abstract
Background
Most of the weight loss with the BioEnterics intragastric balloon (BIB) has occurred during the first 3–4 months. This study aimed to evaluate the effect of initial weight loss on long-term weight maintenance.
Methods
From 2008 to 2011, 50 patients who had mean body mass index (BMI) of 44.7 ± 12.4 kg/m2 underwent BIB therapy for 6 months. All patients were given a diet of 1,100 kcal/day. Weight loss parameters [absolute weight loss, BMI loss, percentage of body weight loss (BWL%), and percentage of excess BMI loss] were recorded at the baseline, 1 month, 6 months (time of BIB removal), 12 months, and 18 months from the baseline. Successful weight loss was defined as ≥10 % weight loss after 6, 12, and 18 months.
Results
Twenty-seven patients (54 %) achieved a percentage of BWL ≥ 10 at the time of removal. Eighteen (36 %) and 12 (24 %) patients were able to maintain weight loss of 10 % at 12 and 18 months. Percentage of BWL after 1 month was positively correlated with BWL% after 6, 12, and 18 months (r = 0.77, 0.65, and 0.62, p < 0.001, respectively). Twenty-four patients who lost 5 % of the BWL after 1 month of treatment succeeded in maintaining a lasting percentage of BWL ≥10 after the BIB removal: more precisely, this cutoff point was achieved in 96 % at the time of removal and in 71 %, 50 % at 12 months, and 18 months of follow-up.
Conclusions
Five percent BWL after 1 month of treatment may be a predictor for long-term weight maintenance.
Similar content being viewed by others
References
Ganesh R, Rao AD, Baladas HG, Leese T. The Bioenteric Intragastric Balloon (BIB) as a treatment for obesity: poor results in Asian patients. Singapore Med J. 2007;48:227–31.
WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva: WHO. 1998.
Allison DB, Fontaine KR, Manson JE, et al. Annual deaths attributable to obesity in the United States. J Am Med Assoc. 1999;282:1530–8.
Health benefits of weight loss (2005). In: www.maso.org.my/spom/chap4.pdf.
Nieben OG, Harboe H. Intragastric balloon as an artificial bezoar for treatment of obesity. Lancet. 1982;1(8265):198–9.
Al-Momen A, El-Mogy I. Intragastric balloon for obesity: a retrospective evaluation of tolerance and efficacy. Obes Surg. 2005;15:101–5.
Kotzampassi K, Grosomanidis V, Papakostas P, et al. 500 intragastric balloons: what happens 5 years thereafter? Obes Surg. 2012;22(6):896–903.
Saruç M, Böler D, Karaarslan M, et al. Intragastric balloon treatment of obesity must be combined with bariatric surgery: a pilot study in Turkey. Turk J Gastroenterol. 2010;21(4):333–7.
Fernandes M, Atallah AN, Soares BG, et al. Intragastric balloon for obesity. Cochrane Database Syst Rev. 2007;(1): CD00493
Deitel M, Gawdat K, Melissas J. Reporting weight loss 2007. Obes Surg. 2007;17:565–8.
Dumonceau JM. Evidence-based review of the Bioenterics intragastric balloon for weight loss. Obes Surg. 2008;18(12):1611–7.
Imaz I, Martinez-Cervell C, Garcia-Alvarez EE, et al. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis Obes Surg. 2008;18:841–6.
Espinet E, Merlo J, Durán R, et al. Tratamiento endoscópico de la obesidad moderada mediante balón intragástrico. Madrid: II Congreso Nacional de Endoscopia Digestiva; 2007.
García V, Espinet E, Valero M, et al. Importancia de la enfermería en el balón intragástrico endoscópico. Murcia: XV Jornada Nacional de la AEEED; 2006.
Carbonelli MG, Fusco MA, Cannistra F, et al. Body composition modification in obese patients treated with intragastric balloon. Acta Diabetol. 2003;40(1):S261–2.
Escudero-Sanchís A, Catalán Serra I, Gonzalvo Sorribes J, et al. Efectividad, seguridad y tolerancia del balón intragástrico asociado a una dieta hipocalórica para la reducción de peso en pacientes obesos. Rev Esp Enferm Dig. 2008;100(6):349–54.
Mathus-Vliegen EM, Tytgat GN. Intragastric balloon for treatment resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest Endosc. 2005;61(1):19–27.
Herve J, Wahlen CH, Schaeken A, et al. What becomes of patients one year after the intragastric balloon has been removed? Obes Surg. 2005;15(6):864–70.
Doldi SB, Micheletto G, Perrini MN, et al. Intragastric balloon: another option for treatment of obesity and morbid obesity. Hepato-Gastroenterology. 2004;51:294–7.
Melissas J, Mouzas J, Filis D, et al. The intragastric balloon—smoothing the path to bariatric surgery. Obes Surg. 2006;16:897–902.
Angrisani L, Lorenzo M, Borrelli V, et al. Is bariatric surgery necessary after intragastric balloon treatment? Obes Surg. 2006;16:1135–7.
Ohta M, Kitano S, Kai S, et al. Initial Japanese experience with intragastric balloon placement. Obes Surg. 2009;19(6):791–5.
Totté E, Hendrickx L, Pauwels M, et al. Weight reduction by means of intragastric device: experience with the Bioenterics intragastric balloon. Obes Surg. 2001;11:519–23.
Conflict of interest
Dr. Umit Bilge Dogan, Dr. Yuksel Gumurdulu, Dr. Mustafa Salih Akin, and Dr. Serkan Yalaki have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dogan, U.B., Gumurdulu, Y., Akin, M.S. et al. Five Percent Weight Lost in the First Month of Intragastric Balloon Treatment May Be a Predictor for Long-Term Weight Maintenance. OBES SURG 23, 892–896 (2013). https://doi.org/10.1007/s11695-013-0876-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-013-0876-4